Diversification of response to hsp65 during the course of autoimmune arthritis is regulatory rather than pathogenic

Determinant spreading has been implicated in the pathogenesis of certain autoimmune diseases in animal models. We have observed that during the course of adjuvant arthritis (AA) in the Lewis rat, there is ‘diversification’ of response to the bacterial 65‐kDa heat shock protein (Bhsp65) towards its c...

Full description

Saved in:
Bibliographic Details
Published inImmunological reviews Vol. 164; no. 1; pp. 175 - 184
Main Author Moudgil, Kamal D.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Determinant spreading has been implicated in the pathogenesis of certain autoimmune diseases in animal models. We have observed that during the course of adjuvant arthritis (AA) in the Lewis rat, there is ‘diversification’ of response to the bacterial 65‐kDa heat shock protein (Bhsp65) towards its carboxy‐terminal determinants (BCTD). Strikingly, pretreatment of naive Lewis rats with BCTD affords significant protection from AA. Our preliminary studies indicate that the diversification of response to BCTD in the Lewis rat is probably triggered in vivo by the induction and enhanced processing of self(rat) hsp65. Thus, the self hsp65‐directed T‐cell responses appear to be involved in mediating natural remission from acute inflammatory arthritis induced by a foreign antigen, Myco‐bacterium tuberculosis. This the first report describing that the new T‐cell specificities arising during the course of an autoimmune disease are regulatory/protective rather than pathogenic. Moreover, our results suggest that a final common mechanism involving BCTD might be recruited by other rac strains which either are resistant to AA (WKY rats) or whose susceptibility to AA is modulated significantly by microbial flora (Fisher rats). The results of this study would contribute significantly to understanding of the pathogenesis of human rheumatoid arthritis, and in devising new therapeutic strategies for this disease.
Bibliography:istex:55D38C85ED3E6A21ACF332DCBFA22E9E34E4F85C
ark:/67375/WNG-X4ZBMMM0-H
ArticleID:IMR175
Acknowledgements
I am grateful to my mentor Dr Eli Sercarz for his support and encouragement in developing my research work in autoimmune arthritis, and for sharing his insights into the fields of antigen processing and presentation and regulation of autoimmunity, and to Dr Bevra Hahn for her encouragement and support in extending my research effort into the area of rheumatic diseases. I am thankful to Dr Ernest Brahn for clarifying the intricacies of the adjuvant arthritis model, and to Dr David Yu for sharing his impressions regarding the biology of heat‐shock proteins. A team of enthusiastic undergraduate students provided valuable technical assistance; Tammy Chang, Herbert Eradat, Oliver Yun, Audrey Chen, Eugene Kim, and Howard Chi. This work was supported by grants from the National Institutes of Health (AR 3683406, AR 42200, AM‐11183), the Arthritis Foundation (Meyer Invesdgator Award: AF/011634, Biomedical Science Grant: AF/IR‐3‐43698), and the Bertram A. Maltz Laboratory of Molecular Rheumatology The author was recipient of grants AR 3683406, AE/011634, and AE/IR‐3‐43698.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0105-2896
1600-065X
DOI:10.1111/j.1600-065X.1998.tb01219.x